株式会社biomyは、人工知能を通じて個別化医療を進展させることに注力するテクノロジー企業です。空間生物学データや病理画像データを含む複雑な生物学的データを分析するためのAIモデルとそれを搭載したプラットフォームを開発しており、生物学への深い洞察を可能にし、治療法の開発を支援することを目指しています。 詳細については、こちらをご覧ください： https://www.biomy-tech.com/ ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology "Scientists can now ...

PLEASANTON, Calif. - 10x Genomics, Inc. (NASDAQ:TXG), a life sciences technology company with a market capitalization of $1.7 billion and impressive gross margins of nearly 70%, announced Tuesday the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

HONG KONG, Feb. 13, 2026 /PRNewswire/ -- Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In Situ ...

HONG KONG, Feb. 13, 2026 /PRNewswire/ — Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In Situ Spatial ...